HomeAI · summaries
Storia in 7 fonti
AstraZeneca quarterly net profit rises 2% on strong cancer drug sales
Strong cancer drug sales lifted Anglo-Swedish pharmaceutical giant AstraZeneca’s second-quarter earnings above expectations, helping the company maintain its 2026 outlook.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
hurriyetdailynews.com
AstraZeneca quarterly net profit rises on strong cancer drug sales - Latest News
British pharmaceutical giant AstraZeneca yesterday said net profit rose in its second quarter, driven once again by strong growth in sales of its cancer drugs.
- ·
independent.co.uk
AstraZeneca sales rise as demand for cancer treatments grow
It reported total revenues of 30.67 billion US dollars for the first six months of 2026.
